The evolving story of the epidermal growth factor receptor as a target for non-small-cell lung cancer.
Lynch
Thomas J
TJ
Harvard Medical School, USA.
D000970:Antineoplastic Agents / Q000494:pharmacology; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D016503:Drug Delivery Systems; D015195:Drug Design; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000235:genetics; D006801:Humans; D009154:Mutation
D000970:Antineoplastic Agents; D066246:ErbB Receptors